Mutations of JAK2 and TET2, but not CBL are detectable in a high portion of patients with refractory anemia with ring sideroblasts and thrombocytosis

Ítems similars

• High frequencies of SF3B1 and JAK2 mutations in refractory anemia with ring sideroblasts associated with marked thrombocytosis strengthen the assignment to the category of myelodysplastic/myeloproliferative neoplasms
  per: Jeromin, Sabine, et al.
  Publicat: (2013)
• Refractory anemia with ring sideroblasts and thrombocytosis
  per: Pradhan, Sarita
  Publicat: (2017)
• Refractory anemia with ring sideroblasts and marked thrombocytosis cases harbor mutations in SF3B1 or other spliceosome genes accompanied by JAK2V617F and ASXL1 mutations
  per: Jeromin, Sabine, et al.
  Publicat: (2015)
• Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis
  per: Broseus, Julien, et al.
  Publicat: (2012)
• Imetelstat therapy in refractory anemia with ring sideroblasts with or without thrombocytosis
  per: Tefferi, A, et al.
  Publicat: (2016)